For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Rockwell Medical Inc’s stock clocked out at $1.59, down -1.85% from its previous closing price of $1.62. In other words, the price has decreased by -$1.85 from its previous closing price. On the day, 2.7 million shares were traded. RMTI stock price reached its highest trading level at $1.67 during the session, while it also had its lowest trading level at $1.52.
Ratios:
To gain a deeper understanding of RMTI’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.43. For the most recent quarter (mrq), Quick Ratio is recorded 2.51 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 0.46 whereas as Long-Term Debt/Eq ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On June 24, 2019, Piper Jaffray started tracking the stock assigning a Overweight rating and target price of $10. On May 13, 2019, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on May 13, 2019, with a $11 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 01 ’25 when Chole Timothy sold 2,868 shares for $0.82 per share. The transaction valued at 2,352 led to the insider holds 128,167 shares of the business.
Neri Jesse sold 886 shares of RMTI for $727 on Jul 01 ’25. The SVP and CFO now owns 126,614 shares after completing the transaction at $0.82 per share. On Jul 01 ’25, another insider, Strobeck Mark, who serves as the President and CEO of the company, sold 6,926 shares for $0.82 each. As a result, the insider received 5,679 and left with 337,752 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMTI now has a Market Capitalization of 54744336 and an Enterprise Value of 50329260. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.62 while its Price-to-Book (P/B) ratio in mrq is 1.80. Its current Enterprise Value per Revenue stands at 0.572 whereas that against EBITDA is 56.171.
Stock Price History:
The Beta on a monthly basis for RMTI is 1.80, which has changed by -0.580475 over the last 52 weeks, in comparison to a change of 0.18189907 over the same period for the S&P500. Over the past 52 weeks, RMTI has reached a high of $5.15, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is 40.13%, while the 200-Day Moving Average is calculated to be 8.79%.
Shares Statistics:
It appears that RMTI traded 1.01M shares on average per day over the past three months and 4993410 shares per day over the past ten days. A total of 34.43M shares are outstanding, with a floating share count of 28.93M. Insiders hold about 15.97% of the company’s shares, while institutions hold 17.11% stake in the company. Shares short for RMTI as of 1755216000 were 175071 with a Short Ratio of 0.17, compared to 1752537600 on 152280. Therefore, it implies a Short% of Shares Outstanding of 175071 and a Short% of Float of 0.5700000000000001.
Earnings Estimates
The market rating of Rockwell Medical Inc (RMTI) is currently shaped by the ongoing analysis conducted by 2.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.04 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.17 and -$0.18 for the fiscal current year, implying an average EPS of -$0.17. EPS for the following year is -$0.13, with 2.0 analysts recommending between -$0.09 and -$0.17.
Revenue Estimates
In the current quarter, 2 analysts expect revenue to total $16.24M. It ranges from a high estimate of $16.8M to a low estimate of $15.69M. As of the current estimate, Rockwell Medical Inc’s year-ago sales were $28.32MFor the next quarter, 2 analysts are estimating revenue of $17.15M. There is a high estimate of $18.13M for the next quarter, whereas the lowest estimate is $16.17M.
A total of 2 analysts have provided revenue estimates for RMTI’s current fiscal year. The highest revenue estimate was $69.91M, while the lowest revenue estimate was $66.84M, resulting in an average revenue estimate of $68.37M. In the same quarter a year ago, actual revenue was $101.49MBased on 2 analysts’ estimates, the company’s revenue will be $75.89M in the next fiscal year. The high estimate is $81.59M and the low estimate is $70.18M.